Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Townend

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|June 2, 2011
How we took control and became more efficientMichael Griffith, Jonathan Townend
Eclinicalmedicine|January 19, 2026
Major adverse cardiovascular events after liver transplantation: a population cohort analysis of English transplant centresFelicity Evison, Suzy Gallier, Fatima Malik, et al.
BMJ (Clinical Research Ed.)|September 1, 2015
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataOliver J Ziff, Deirdre A Lane, Monica Samra, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2015
Renal Denervation in Patients With Uncontrolled Hypertension and Confirmed Adherence to Antihypertensive MedicationsMohammed Awais Hameed, Mark Pucci, Una Martin, et al.
International Journal of Cardiology|September 14, 2015
Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user groupFrancesco Burzotta, Carlo Trani, Sagar N Doshi, et al.
Heart (British Cardiac Society)|November 25, 2024
Changes in peak oxygen consumption in Fabry disease and associations with cardiomyopathy severityAshwin Roy, Sophie E Thompson, James Hodson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 23, 2015
Reduced Cardiovascular Reserve in Chronic Kidney Failure: A Matched Cohort StudyStephen M S Ting, Thomas Hamborg, Gordon McGregor, et al.
Trials|June 3, 2014
Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trialNathan R Hill, Daniel Lasserson, Ben Thompson, et al.
Trials|December 12, 2022
Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trialNathan R Hill, Daniel Lasserson, Ben Thompson, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2015
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant dataKunihiro Matsushita, Josef Coresh, Yingying Sang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|June 2, 2011
How we took control and became more efficientMichael Griffith, Jonathan Townend
Eclinicalmedicine|January 19, 2026
Major adverse cardiovascular events after liver transplantation: a population cohort analysis of English transplant centresFelicity Evison, Suzy Gallier, Fatima Malik, et al.
BMJ (Clinical Research Ed.)|September 1, 2015
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataOliver J Ziff, Deirdre A Lane, Monica Samra, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2015
Renal Denervation in Patients With Uncontrolled Hypertension and Confirmed Adherence to Antihypertensive MedicationsMohammed Awais Hameed, Mark Pucci, Una Martin, et al.
International Journal of Cardiology|September 14, 2015
Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user groupFrancesco Burzotta, Carlo Trani, Sagar N Doshi, et al.
Heart (British Cardiac Society)|November 25, 2024
Changes in peak oxygen consumption in Fabry disease and associations with cardiomyopathy severityAshwin Roy, Sophie E Thompson, James Hodson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 23, 2015
Reduced Cardiovascular Reserve in Chronic Kidney Failure: A Matched Cohort StudyStephen M S Ting, Thomas Hamborg, Gordon McGregor, et al.
Trials|June 3, 2014
Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trialNathan R Hill, Daniel Lasserson, Ben Thompson, et al.
Trials|December 12, 2022
Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trialNathan R Hill, Daniel Lasserson, Ben Thompson, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2015
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant dataKunihiro Matsushita, Josef Coresh, Yingying Sang, et al.
Pageof 1